RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 99 filers reported holding RAPT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,957,861 | -15.7% | 177,970 | -5.2% | 0.00% | 0.0% |
| Q2 2023 | $3,509,598 | +9.9% | 187,679 | +7.8% | 0.00% | 0.0% |
| Q1 2023 | $3,194,056 | -18.5% | 174,063 | -12.0% | 0.00% | 0.0% |
| Q4 2022 | $3,918,024 | -1.8% | 197,880 | +19.3% | 0.00% | 0.0% |
| Q3 2022 | $3,991,000 | +681.0% | 165,844 | +493.1% | 0.00% | – |
| Q2 2022 | $511,000 | -54.0% | 27,961 | -44.7% | 0.00% | – |
| Q1 2022 | $1,112,000 | -16.5% | 50,602 | +39.5% | 0.00% | – |
| Q4 2021 | $1,332,000 | +35.9% | 36,261 | +14.9% | 0.00% | – |
| Q3 2021 | $980,000 | -61.9% | 31,563 | -61.0% | 0.00% | -100.0% |
| Q2 2021 | $2,569,000 | +1031.7% | 80,840 | +689.1% | 0.00% | – |
| Q1 2021 | $227,000 | -30.4% | 10,245 | -38.0% | 0.00% | – |
| Q4 2020 | $326,000 | -87.3% | 16,513 | -81.3% | 0.00% | -100.0% |
| Q2 2020 | $2,564,000 | – | 88,343 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 2,680,621 | $44,551,921 | 29.58% |
| GREAT POINT PARTNERS LLC | 1,458,070 | $24,233,123 | 4.41% |
| Euclidean Capital LLC | 1,315,798 | $21,868,562 | 2.39% |
| Trustees of Columbia University in the City of New York | 73,383 | $1,219,625 | 2.24% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 805,828 | $13,392,861 | 1.54% |
| Perceptive Advisors | 1,920,658 | $31,921,336 | 1.06% |
| Deep Track Capital, LP | 1,500,000 | $24,930,000 | 0.96% |
| Cheyne Capital Management (UK) LLP | 20,000 | $332,400 | 0.96% |
| Alphabet Inc. | 540,270 | $8,979,287 | 0.58% |
| BRAIDWELL LP | 1,082,512 | $17,991,349 | 0.57% |